Literature DB >> 18324973

beta(2)-Adrenergic receptor and adenylate cyclase gene polymorphisms affect sickle red cell adhesion.

Christine E Eyler1, Terry Jackson, Laine E Elliott, Laura M De Castro, Jude Jonassaint, Allison Ashley-Koch, Marilyn J Telen.   

Abstract

Sickle red cell (SS RBC) adhesion is thought to contribute to sickle cell disease (SCD) pathophysiology. SS RBC adhesion to laminin increases in response to adrenaline stimulation of beta(2)-adrenergic receptors (beta(2)ARs) and adenylate cyclase (ADCY6), and previous evidence suggests such activation occurs in vivo. We explored whether polymorphisms of the beta(2)AR and ADCY6 genes (ADRB2 and ADCY6, respectively) affect RBC adhesion to laminin. We found that the beta(2)AR arg(16)-->gly substitution and two non-coding ADCY6 polymorphisms were associated with elevated adhesion. We postulate that ADRB2 and ADCY6 polymorphisms may influence SCD severity through the mechanism of RBC adhesion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324973     DOI: 10.1111/j.1365-2141.2008.07008.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

2.  Regulation of Active ICAM-4 on Normal and Sickle Cell Disease RBCs via AKAPs Is Revealed by AFM.

Authors:  Jing Zhang; Krithika Abiraman; Sasia-Marie Jones; George Lykotrafitis; Biree Andemariam
Journal:  Biophys J       Date:  2017-01-10       Impact factor: 4.033

3.  Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.

Authors:  Ambroise Wonkam; Khuthala Mnika; Valentina J Ngo Bitoungui; Bernard Chetcha Chemegni; Emile R Chimusa; Collet Dandara; Andre P Kengne
Journal:  Br J Haematol       Date:  2017-12-03       Impact factor: 6.998

4.  Sickle cell disease: selected aspects of pathophysiology.

Authors:  T Alexy; S Sangkatumvong; P Connes; E Pais; J Tripette; J C Barthelemy; T C Fisher; H J Meiselman; M C Khoo; T D Coates
Journal:  Clin Hemorheol Microcirc       Date:  2010       Impact factor: 2.375

Review 5.  International Union of Basic and Clinical Pharmacology. CI. Structures and Small Molecule Modulators of Mammalian Adenylyl Cyclases.

Authors:  Carmen W Dessauer; Val J Watts; Rennolds S Ostrom; Marco Conti; Stefan Dove; Roland Seifert
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

6.  Effect of propranolol as antiadhesive therapy in sickle cell disease.

Authors:  Laura M De Castro; Rahima Zennadi; Jude C Jonassaint; Milena Batchvarova; Marilyn J Telen
Journal:  Clin Transl Sci       Date:  2012-10-17       Impact factor: 4.689

7.  Sickle Cell Disease in the Post Genomic Era: A Monogenic Disease with a Polygenic Phenotype.

Authors:  A Driss; K O Asare; J M Hibbert; B E Gee; T V Adamkiewicz; J K Stiles
Journal:  Genomics Insights       Date:  2009-07-30

Review 8.  Physiological roles of mammalian transmembrane adenylyl cyclase isoforms.

Authors:  Katrina F Ostrom; Justin E LaVigne; Tarsis F Brust; Roland Seifert; Carmen W Dessauer; Val J Watts; Rennolds S Ostrom
Journal:  Physiol Rev       Date:  2021-10-26       Impact factor: 37.312

9.  Sickle cell disease biochip: a functional red blood cell adhesion assay for monitoring sickle cell disease.

Authors:  Yunus Alapan; Ceonne Kim; Anima Adhikari; Kayla E Gray; Evren Gurkan-Cavusoglu; Jane A Little; Umut A Gurkan
Journal:  Transl Res       Date:  2016-03-19       Impact factor: 7.012

Review 10.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.